Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8794
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders ; volume:12 ; number:1 ; day:7 ; month:3 ; year:2019 ; pages:1-11 ; date:12.2019
BMC medical genomics ; 12, Heft 1 (7.3.2019), 1-11, 12.2019
- Urheber
-
Biagi, Elena
Zama, Daniele
Rampelli, Simone
Turroni, Silvia
Brigidi, Patrizia
Consolandi, Clarissa
Severgnini, Marco
Picotti, Eleonora
Gasperini, Pietro
Merli, Pietro
Decembrino, Nunzia
Zecca, Marco
Cesaro, Simone
Faraci, Maura
Prete, Arcangelo
Locatelli, Franco
Pession, Andrea
Candela, Marco
Masetti, Riccardo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12920-019-0494-7
- URN
-
urn:nbn:de:101:1-2019033115035903994812
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Biagi, Elena
- Zama, Daniele
- Rampelli, Simone
- Turroni, Silvia
- Brigidi, Patrizia
- Consolandi, Clarissa
- Severgnini, Marco
- Picotti, Eleonora
- Gasperini, Pietro
- Merli, Pietro
- Decembrino, Nunzia
- Zecca, Marco
- Cesaro, Simone
- Faraci, Maura
- Prete, Arcangelo
- Locatelli, Franco
- Pession, Andrea
- Candela, Marco
- Masetti, Riccardo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Quality of life among hematological cancer survivors following allogeneic hematopoietic stem cell transplantation : = Lebensqualität bei hämatologischen Krebspatienten nach allogener Stammzelltransplantation
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies
Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Quality of life among hematological cancer survivors following allogeneic hematopoietic stem cell transplantation : = Lebensqualität bei hämatologischen Krebspatienten nach allogener Stammzelltransplantation
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies
Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Quality of life among hematological cancer survivors following allogeneic hematopoietic stem cell transplantation : = Lebensqualität bei hämatologischen Krebspatienten nach allogener Stammzelltransplantation
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies
Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review